Skip to content
  1. Industries
  2. Pharma & Life Sciences

Industry

AI for Pharma & Life Sciences: Audit-Ready, Built to GxP Expectations

From clinical evidence to HCP compliance, we build AI that meets pharma's regulatory requirements from day one.

Clients on record · Continuous delivery since 2014

  • Bayer
  • Takeda
  • Adidas
  • Rockwell Automation
  • Burckhardt Compression
  • Tillotts Pharma
  • WS Audiology
  • Sivantos
  • Widex
  • Reebok
  • Zeppelin
  • DEVK
  • Arcondis
  • Fuel3D
  • Qatar Post
  • Generac
  • Floww.io

Challenges

What we see in the field.

  1. GxP validation slows AI adoption

    IQ/OQ/PQ, 21 CFR Part 11, full audit trails. Most AI vendors have never been through pharma validation. The gap between what they promise and what passes QA is enormous.

  2. HCP engagement compliance is manual and slow

    Every communication needs review. Teams spend more time on compliance than engagement. The review bottleneck limits how fast your field teams can operate.

  3. Clinical evidence volumes overwhelm manual processes

    Thousands of new publications monthly. Teams can't read everything but are responsible for knowing everything. Manual literature review doesn't scale.

  4. Pharmacovigilance can't keep up

    AE reports from trials, spontaneous reports, literature, social media growing exponentially. Signal detection at the speed and scale required is beyond manual capability.

Use cases

Real-world applications.

Adverse event case triage

Illustrative scenario, not a QueryNow client result. Pharmacovigilance intake runs around 30 hours a week for a mid-size portfolio: inbox triage, free-text classification, Argus fields re-keyed from call-center transcripts. We build the agent that triages and structures the cases, in your validated environment.

Example input: 30 hrs/week of case intake

Medical information request responses

Illustrative scenario, not a QueryNow client result. Your team writes the same set of medical information letters every month: the product, the indication, the citation set, the reviewer cycles. We build the agent that drafts them to your standard against a real inbox.

Example input: ~40 letters per month

Our method

From one workflow to a validated tool in daily use.

  1. Scope and sign

    Before the build

    We define the workflow and its acceptance criteria with you. Both are agreed in writing before work starts.

  2. Build

    In your environment

    We build the tool in your environment and test it against your own data and every criterion you signed.

  3. Run

    After launch

    We run and improve the tool after launch, measured against the same criteria, with your team approving what it produces.

Compliance & security

  • Built to SOC 2, HIPAA and GDPR standards
  • EU AI Act-aligned delivery
  • 21 CFR Part 11
  • EU MDR
  • ICH Guidelines
  • Pharmacovigilance Regs
  • EMA Standards

Frequently asked

Questions buyers ask.

How do you handle GxP validation for AI systems?

We take a risk-based approach. When an AI workflow creates or changes GxP records, we validate it under your quality system in line with GAMP 5, and deliver the IQ/OQ/PQ documentation your QA team requires. Workflows that only draft text for a person to review and sign stay outside the validated boundary, with audit trails, access controls and electronic signatures where 21 CFR Part 11 applies.

Can the AI integrate with our existing pharma systems?

Yes. We integrate with Veeva Vault, IQVIA, Medidata, SAP for Life Sciences, and other pharma-specific platforms. The AI reads from your systems of record without modifying validated data.

How does the AI handle adverse event detection across data sources?

Our pharmacovigilance AI monitors clinical trial databases, spontaneous reporting systems, published literature, and real-world evidence simultaneously. It uses NLP to identify potential safety signals across structured and unstructured sources, then routes findings to safety teams for medical review.

Is the system compliant with both FDA and EMA requirements?

We design for both. The same system can carry 21 CFR Part 11 controls for FDA-regulated records and GDPR data residency for European operations, so multi-region teams can run one setup. Your quality and regulatory teams confirm compliance for each use.

What is the typical timeline for deploying pharma AI?

We scope one workflow with you and agree the acceptance criteria in writing, then build it in your environment. Where a workflow creates or changes GxP records, we include the validation documentation your QA team requires. Larger programs run as a sequence of builds, one workflow at a time, and the timeline is set in the statement of work.

Research paper

Compliance-grade RAG: Retrieval systems a regulator can audit

How to build retrieval that a regulated reviewer can trust and audit.

Read the paper

PDF, free

Ready to start with one workflow?

Talk to our team about the workflow you want to start with. Every engagement starts with one scoped workflow and a written definition of done. Commercial terms are set in the statement of work.

  • Built to SOC 2, HIPAA and GDPR standards
  • EU AI Act-aligned delivery
  • Microsoft Solutions Partner